The Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business, for the supply of radiopharmaceuticals. The $740,177.94 contract is part of a larger $39.8 million multiple-award Indefinite Delivery Contract (IDC) with the VA's Network Contracting Office 8, as well as additional IDVs with the VA and Defense Health Agency (DHA) worth up to $6.6 million. These contracts enable the VA and DHA to efficiently procure critical nuclear medicine products, such as Ga-68 Dotatate, iodine I-123, and technetium-99m, which are used in diagnostic imaging and cancer treatment procedures for veterans and military personnel across the United States. The contract has an ultimate completion date of January 31, 2028.
Generated 2/11/25, 10:15 AM